Eli Lilly and

Eli Lilly and

Yahoo Finance • 6 hours ago

CNS Summit Announces Sanofi as No. 1 in the 2026 Digital Innovation Index

BOSTON, Nov. 4, 2026 /PRNewswire/ -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index, developed in collaboration with IDEA Pharma, a division of SAI MedPartners, placing in the top three in all three categories. The ran... Full story

Yahoo Finance • 7 hours ago

National Advertising Division Recommends Good Life Discontinue Health Benefit and Personalization Claims for Compounded Tirzepatide+ Products

BBB NATIONAL PROGRAMS In a challenge brought by Eli Lilly and Company, BBB National Programs' National Advertising Division recommended that Good Life Meds, LLC discontinue the challenged express health benefit and personalization claims... Full story

Yahoo Finance • 8 hours ago

What Wall Street is Missing About Micron’s (MU) Ultra-Low Earnings Multiple

We just published the list of the 10 Best Tech Stocks for the Next 5 Years and Micron Technology (MU) ranked 8th on this list. Big Tech just had a week investors will remember. At its low on Friday, Alphabet had lost $477 billion in marke... Full story

Yahoo Finance • 8 hours ago

Novo Nordisk Stock Shrugs Off Eli Lilly Threat as Weight-Loss Pill Shines in Earnings

The Danish drugmaker has had a dismal year, but its third-quarter earnings on Wednesday finally gave the market a reason to feel hopeful. Continue Reading... Full story

Yahoo Finance • 9 hours ago

Novo Nordisk Weight-Loss Pill Sales Soar. One Other Earnings Revelation Boosting the Stock.

The Danish drugmaker has had a dismal year, but its third-quarter earnings on Wednesday finally gave the market a reason to feel hopeful. Continue Reading... Full story

Yahoo Finance • 11 hours ago

Treasury's Refunding Details Are Up Next as Five Large Companies Report Higher Revenue

NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Market Updates News Commentary - U.S. stock index futures were mixed early Wednesday after a split session on Tuesday. As of 2:22 a.m. ET, December E-mini S&P 500 futures were down 0.22% at 7,579.75 a... Full story

Yahoo Finance • 12 hours ago

Capital Group Cons. Equity (CGCV) Adds Microsoft and Philip Morris on Monday

This article first appeared on GuruFocus. Capital Group Conservative Equity ETF (CGCV) recorded net buying of $158.6 million on Monday, Nov. 2, with gross ETF activity matching that figure as the fund made no sales. All 69 positions that... Full story

Yahoo Finance • 12 hours ago

State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 2

This article first appeared on GuruFocus. State Street Health Care Select Sector SPDR ETF (XLV) was buying on Monday, with 60 positions increased and none decreased, and no ETFs selling. The fund's ETF activity totaled $175.3 million boug... Full story

Yahoo Finance • 12 hours ago

Capital Group Dividend Value (CGDV) Buys $146.3 Million More AMAT on Nov. 2

This article first appeared on GuruFocus. In ETF activity on Monday, Capital Group Dividend Value ETF (CGDV) increased 35 positions and trimmed 14, with gross trades of $1.20 billion against $38.77 billion in assets. CGDV bought $146.3 mi... Full story

Yahoo Finance • 12 hours ago

42 ETFs Add to Lilly (LLY) Holdings on Nov. 2

This article first appeared on GuruFocus. Forty-two ETFs were buying Eli Lilly (LLY) shares versus 24 selling on Monday, a net $105.3 million of ETF flows into the stock. The buying extended a five-day streak of net inflows. On Oct. 30, 4... Full story

Yahoo Finance • 14 hours ago

Novo improves outlook on continued demand for Wegovy pill, Ozempic

[New Nordisk] hapabapa/iStock Editorial via Getty Images Novo (NVO [https://seekingalpha.com/symbol/NVO]) raised its outlook for the year once again, driven by continued demand for its Wegovy weight-loss pill, and its older shot Ozempic.... Full story

Yahoo Finance • yesterday

Raised Guidance Altering The Investment Case For Eli Lilly Stock?

Eli Lilly reported Q3 2026 sales of US$24.4b and net income of US$6.5b, raised full-year revenue guidance to a range of US$91b to US$92b, and released clinical data across obesity, diabetes, and oncology programs. Beyond headline incretin... Full story

Yahoo Finance • yesterday

Most and least shorted mid- to mega-cap healthcare stocks at the end of October

Short interest data from late October 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in high-volatility biotechnology, equipment, and digital health names, wi... Full story

Yahoo Finance • yesterday

ETFs Bought $147.9 Million of Eli Lilly (LLY) on Oct. 30

This article first appeared on GuruFocus. ETFs bought $147.9 million of Eli Lilly (LLY) on Friday, with 42 funds buying and 22 selling. ETF activity has been positive for five straight sessions, including $40.6 million on Thursday and $36... Full story

Yahoo Finance • 2 days ago

Clean Sweep for Seven Companies in Extel’s 2026 U.S. Corporates Survey

Delta, Eli Lilly, JPMorgan Chase, NVIDIA, Quanta Services, Thermo Fisher Scientific and Visa took first place in every category for their sectors. Walmart recorded the 2026 survey's highest weighted score. NEW YORK, November 03, 2026--(BU... Full story

Yahoo Finance • 2 days ago

Eli Lilly Stocks Move Lower With Higher Target Facing a Volume-Price Tradeoff

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the diabetes and obesity drugmaker, fell 0.59% to $1,409.21 at 10:00 a.m. ET on November 2, even as Cantor Fitzgerald raised its price target to $1,600 from $1,440 and mainta... Full story

Yahoo Finance • 2 days ago

What Avantis U.S. Equity ETF (AVUS) Bought: Exxon Mobil Leads on Oct. 29

This article first appeared on GuruFocus. Avantis U.S. Equity ETF (AVUS) added to its portfolio last Thursday, with net buying of $213.4 million against $226.2 million in gross ETF activity. The fund increased 434 positions and trimmed 53... Full story

Yahoo Finance • 2 days ago

What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29

This article first appeared on GuruFocus. State Street Health Care Select Sector SPDR ETF (XLV) reported $423.4 million in ETF activity last Thursday, all of it buying. The $49.10 billion fund increased all 60 of its positions and decreas... Full story

Yahoo Finance • 2 days ago

ETFs Bought $22.0 Million of Merck (MRK) on Oct. 29

This article first appeared on GuruFocus. ETFs bought $22.0 million of Merck (MRK) on Thursday, with 36 funds adding shares against 20 that sold. ETF activity has favored the stock for four straight sessions, including $19.1 million on We... Full story

Yahoo Finance • 2 days ago

UnitedHealth (UNH) Sees $35.0 Million in Net ETF Buying on Oct. 29

This article first appeared on GuruFocus. ETF flows into UnitedHealth stretched to a fourth straight day on Thursday, with $35.0 million in net buying. That followed net purchases of $17.8 million on Wednesday, $16.4 million on Tuesday an... Full story